In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
about
In vivo efficacy of ceftaroline fosamil in a methicillin-resistant panton-valentine leukocidin-producing Staphylococcus aureus rabbit pneumonia model.Ceftaroline: A New Cephalosporin with Activity against Methicillin-Resistant Staphylococcus aureus (MRSA)Impact of β-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus.Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia.Ceftaroline in complicated skin and skin-structure infections.Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumoniaIn vitro activity of ceftaroline against clinical isolates of Streptococcus pneumoniae recovered in 43 U.S. medical centers during 2010-2011.Emerging drugs in sepsis.Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens.Ceftaroline for complicated skin and skin-structure infections.Methicillin-resistant Staphylococcus aureus in community-acquired and health care-associated pneumonia: incidence, diagnosis, and treatment options.Ceftaroline fosamil: a new broad-spectrum cephalosporin.Emerging drugs for pneumococcal pneumonia.Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections.Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamil.Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.Antimicrobial activity of ceftaroline tested against drug-resistant subsets of Streptococcus pneumoniae from U.S. medical centers.Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.Evaluation of ceftaroline activity versus ceftriaxone against clinical isolates of Streptococcus pneumoniae with various susceptibilities to cephalosporins in an in vitro pharmacokinetic/pharmacodynamic model.The discovery of ceftazidime/avibactam as an anti-Mycobacterium avium agent.Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.Evaluation of ceftaroline activity versus daptomycin (DAP) against DAP-nonsusceptible methicillin-resistant Staphylococcus aureus strains in an in vitro pharmacokinetic/pharmacodynamic model.Postantibiotic effect of ceftaroline against gram-positive organisms.Molecular docking and molecular dynamics studies on β-lactamases and penicillin binding proteins.Common Occurrence of Ceftriaxone-Resistant, Methicillin-Sensitive Staphylococcus aureus at a Community Teaching Hospital
P2860
Q33622755-331DCC40-98C5-4E91-AB5C-256FF15FD426Q35117981-1C296D20-15F5-4E72-9B3E-4A2A90A80436Q35385697-217332DE-2F86-4E8D-9319-E26779A0AB79Q35408518-54405C7B-4410-4972-9172-058AC97B93B0Q35715381-3B9AB985-AF65-4740-AFB9-F1CCE23D4365Q35752997-A4D592F1-AF74-4CBF-B12F-DF68EBBB5F48Q36018756-D169ADAA-C5AA-4156-B67E-2B6751BA63A2Q37670186-A8CFAA95-7C4A-41F6-B249-A142ABFE82C1Q37718228-058E038D-15BE-4CA2-8651-7528D7181C40Q37733561-DAE2288C-1711-45FA-9A31-529F58AF221BQ37752231-0A18A8E9-CD8F-4B8D-92B8-3CF066B80955Q37863942-A0966174-51BF-46F6-877E-7CBBB88C51A5Q37864327-5A414F13-D7D9-4181-8F8C-3E2E4771B58EQ37947221-EE4464D9-4A42-4A1B-BD9C-D393D3C598DDQ38006689-F5BDB1B5-D9E9-4637-AA67-B12CF16B5601Q38025132-03F7F1DB-22E4-4642-ABB5-339C46132880Q38035808-136C0FEF-1BAD-4E65-8B95-B5D4F1692A58Q38061168-C541F159-55EC-4DFA-BFB5-62F2F5B56B3DQ38117077-DAE96B12-9112-4125-9076-276AA72766A0Q38262950-7A041A6C-75B1-4BE0-B4F4-229CB5C0E821Q39048083-6051C276-5AEC-4F98-A898-1B3E37528829Q39682573-3BB01F6C-42D5-48E1-9190-71A19D5F9E81Q40335746-A61DFF70-8DA6-4B0D-9BBA-9CFDCEAAB4C9Q41985451-591CBDC0-EF7D-42E2-AC6E-2AA8D2651F30Q41996889-8DC5111F-68F9-4809-AC57-189A310B6918Q42111061-2839944A-A69D-4C8B-8C5D-5037FAD46331Q42131112-7A62B6EC-5647-42A5-9550-EDB309F059A9Q42586753-0605E6C6-BAB7-4BB9-A34E-4C32AE28A479Q54295530-8D9D6D63-DA36-4F22-A574-8798FA701DC4Q56523540-443B7315-68B2-4346-B6DD-537FD100EA59
P2860
In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
In vitro evaluation of the ant ...... s of Streptococcus pneumoniae.
@en
In vitro evaluation of the ant ...... s of Streptococcus pneumoniae.
@nl
type
label
In vitro evaluation of the ant ...... s of Streptococcus pneumoniae.
@en
In vitro evaluation of the ant ...... s of Streptococcus pneumoniae.
@nl
prefLabel
In vitro evaluation of the ant ...... s of Streptococcus pneumoniae.
@en
In vitro evaluation of the ant ...... s of Streptococcus pneumoniae.
@nl
P2093
P2860
P356
P1476
In vitro evaluation of the ant ...... s of Streptococcus pneumoniae.
@en
P2093
Anthony M Smith
Bernard Beall
Cynthia G Whitney
Donald Biek
Lesley McGee
Magderie Klugman
P2860
P304
P356
10.1128/AAC.01324-08
P407
P577
2008-11-17T00:00:00Z